Skip to main content
Twitter
About Us
NDEWS Overview
People
Drugs
Drug Information
Drug Outbreak Testing Service (DOTS)
New Psychoactive Substance (NPS)
Toxicology Case Studies - ACMT
NDEWS News Scans
Social Media Data Mining
Project Publications
Publications
HotSpot Reports
Sentinel Sites
Sentinel Sites: Reports and Epidemiologists
Cross-Site Data Presentation
Resources
NDEWS Presents Webinars
Community Drug Early Warning System (CDEWS)
Drug Surveillance Systems in Other Countries
National and State Data Sources
Supervised Injection Research and Policy
Outside Publications
Conferences and Meetings
Data
About Us
NDEWS Overview
People
Drugs
Drug Information
Drug Outbreak Testing Service (DOTS)
New Psychoactive Substance (NPS)
Toxicology Case Studies - ACMT
NDEWS News Scans
Social Media Data Mining
Project Publications
Publications
HotSpot Reports
Sentinel Sites
Sentinel Sites: Reports and Epidemiologists
Cross-Site Data Presentation
Resources
NDEWS Presents Webinars
Community Drug Early Warning System (CDEWS)
Drug Surveillance Systems in Other Countries
National and State Data Sources
Supervised Injection Research and Policy
Outside Publications
Conferences and Meetings
Data
Search
Search
Enter the terms you wish to search for.
Publications related to outside publications
Guy G.P. Jr., Zhang K., Bohm M.K., et al. (2017). Vital Signs: Changes in Opioid Prescribing in the United States, 2006–2015. MMWR Morbidity and Mortality Weekly Rep, 66:697–704.
Hockenhull, J., Murphy, K.G., & Paterson, S. (2017). An Observed Rise in y-hydroxybutyrate-associated Deaths in London: Evidence to Suggest a Possible Link with Concomitant Rise in Chemsex. Forensic Science International, 270: 93-97.
Inter-American Drug Abuse Control Commission. (2017). Analysis of the Chemical Composition of Smokable Cocaine Substances. Subregional Compendium. Organization of American States
Kristof, N. (2017). How to win a war on drugs: Portugal treats addiction as a disease, not a crime. New York Times. New York, NY.
Mack, K.A., Jones, C.M., & Ballesteros, M.F. (2017). Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas — United States. MMWR Surveillance Summaries, 66(19):1-8.
Mars, S., Ondocsin, J., & Ciccarone, D. (2017). Sold as Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD. Journal of Psychoactive Drugs, 50(2): 167-76.
National Institutes of Health. (2017). Vaping popular among teens; opioid misuse at historic lows. News Release - Monitoring the Future Survey.
Office of National Drug Control Policy. (2017). Acrylfentanyl and Naloxone Effectiveness.
ondcp-press-release-nalxone-effectiveness-july2017.pdf
60.77 KB
President’s Commission on Combating Drug Addiction and the Opioid Crisis. (2017). Final Report of the Commission.
Stewart, K., Cao, Y., Hsu, M.H., Artigiani, E.E., & Wish, E. (2017). “Geospatial Analysis of Drug Poisoning Deaths Involving Heroin in the United States, 2000-2014,” Journal of Urban Health, 94(4):572-586.
Tanum, L., Solli, K.K., Latif, Z.E., Benth,J.S., Opheim, A., Sharma-Haase, K, Krajci, P., & Kunoe, N. (2017). Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence. JAMA Psychiatry, 74(12):1197-1205.
The Global Commission on Drug Policy. (2017). The World Drug Perception Problem: Countering Prejudices About People Who Use Drugs.
Tirrell, M. (2017). As Opioid Epidemic Worsens, the Cost of Waking up from an Overdose Soars. CNBC.
United Nations Office on Drugs and Crime (UNODC). (2017). Non-medical use of benzodiazepines: a growing threat to public health? Global SMART Update.
Volkow, N.D. (2017). Medications for opioid use disorder: bridging the gap in care. The Lancet, 391(10118): 285-7.
White House Council of Economic Advisors. (2017). The Underestimated Cost of the Opioid Crisis.
Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes; Michelle R. Peace, Karen E. Butler, Carl E. Wolf, Justin L. Poklis and Alphonse Poklis
Concentration of Nicotine and Glycols in 27 Electronic Cigarette Formulations; Michelle R. Peace, Tyson R. Baird, Nathaniel Smith, Carl E. Wolf, Justin L. Poklis, and Alphonse Poklis
Analysis of a Commercial Marijuana e-Cigarette Formulation; Michelle R. Peace1, Joseph W. Stone, Justin L. Poklis, Joseph B M. Turner, and Alphonse Poklis
Alcohol, Other Drugs, and Health. (2016). Exploration of the Complex Interrelationship Between Nonmedical Use of Prescription Opioids and Heroin Use
Adamowicz, P. Gieron, J. (2016). Acute Intoxication of Four Individuals Following Use of the Synthetic Cannabinoid MAB-CHMINACA. Clinical Toxicology.
Adams, AJ., Banister, SD., Irizarry, L., Trecki, J., Schwartz, M., Gerona, R. (2016). "Zombie" Outbreak Caused by Synthetic Cannabinoid AMB-FUBINACA in New York. The New England Journal of Medicine.
Armstrong, D. (2016). Drug Maker Thwarted Plan to Limit OxyContin Prescriptions at Dawn of Opioid Epidemic. Stat.
Banta-Green, C., Brewer, AJ., Ort, C., Helsel, DR., Williams, JR., Field, JA. (2016). Using Wastewater-based Epidemiology to Estimate Drug Consumption-Statistical Analyses and Data Presentation.
Bernstein, L. (2016). Landmark Report by Surgeon General Calls Drug Crisis 'A Moral Test for America.' The Washington Post.
Pagination
First page
« First
Previous page
‹ Previous
Page
1
Page
2
Current page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Next page
Next ›
Last page
Last »